Annual FCF
-$108.02 M
-$6.92 M-6.84%
December 31, 2021
Summary
- As of February 8, 2025, ALBO annual free cash flow is -$108.02 million, with the most recent change of -$6.92 million (-6.84%) on December 31, 2021.
- During the last 3 years, ALBO annual FCF has fallen by -$81.16 million (-302.13%).
Performance
ALBO Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly FCF
-$29.67 M
+$7.41 M+19.98%
September 30, 2022
Summary
- As of February 8, 2025, ALBO quarterly free cash flow is -$29.67 million, with the most recent change of +$7.41 million (+19.98%) on September 30, 2022.
- Over the past year, ALBO quarterly FCF has dropped by -$2.00 million (-7.23%).
Performance
ALBO Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM FCF
-$116.28 M
-$2.00 M-1.75%
September 30, 2022
Summary
- As of February 8, 2025, ALBO TTM free cash flow is -$116.28 million, with the most recent change of -$2.00 million (-1.75%) on September 30, 2022.
- Over the past year, ALBO TTM FCF has increased by +$6.05 million (+4.94%).
Performance
ALBO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ALBO Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -6.8% | -7.2% | +4.9% |
| 3 y3 years | -302.1% | -110.1% | -117.5% |
| 5 y5 years | -289.2% | -466.9% | -117.5% |
ALBO Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | +113.6% | +25.0% | +7.6% | at low |
| 5 y | 5-year | +102.1% | at low | +138.9% | +25.0% | +117.5% | +5.2% |
| alltime | all time | +3516.5% | at low | -2923.0% | +25.0% | +3740.2% | +5.2% |
Albireo Pharma Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$29.67 M(-20.0%) | -$116.28 M(+1.8%) |
| Jun 2022 | - | -$37.08 M(+4.0%) | -$114.28 M(+4.9%) |
| Mar 2022 | - | -$35.64 M(+156.6%) | -$108.95 M(+0.9%) |
| Dec 2021 | -$108.02 M(+6.8%) | -$13.89 M(-49.8%) | -$108.02 M(-11.7%) |
| Sep 2021 | - | -$27.67 M(-12.8%) | -$122.33 M(+1.4%) |
| Jun 2021 | - | -$31.75 M(-8.5%) | -$120.63 M(+7.7%) |
| Mar 2021 | - | -$34.72 M(+23.1%) | -$112.03 M(+10.8%) |
| Dec 2020 | -$101.11 M(+89.1%) | -$28.20 M(+8.6%) | -$101.11 M(+18.5%) |
| Sep 2020 | - | -$25.97 M(+12.2%) | -$85.33 M(+16.1%) |
| Jun 2020 | - | -$23.14 M(-2.7%) | -$73.48 M(+15.3%) |
| Mar 2020 | - | -$23.80 M(+91.6%) | -$63.73 M(+19.2%) |
| Dec 2019 | -$53.46 M(+99.0%) | -$12.42 M(-12.1%) | -$53.46 M(+4.7%) |
| Sep 2019 | - | -$14.12 M(+5.4%) | -$51.04 M(+8.1%) |
| Jun 2019 | - | -$13.40 M(-0.9%) | -$47.20 M(+13.9%) |
| Mar 2019 | - | -$13.52 M(+35.3%) | -$41.44 M(+54.3%) |
| Dec 2018 | -$26.86 M(-3.2%) | -$10.00 M(-2.8%) | -$26.86 M(+8.3%) |
| Sep 2018 | - | -$10.29 M(+34.8%) | -$24.82 M(+25.6%) |
| Jun 2018 | - | -$7.63 M(-826.1%) | -$19.76 M(+9.3%) |
| Mar 2018 | - | $1.05 M(-113.2%) | -$18.08 M(-34.9%) |
| Dec 2017 | -$27.76 M(+215.9%) | -$7.95 M(+51.9%) | -$27.76 M(+40.1%) |
| Sep 2017 | - | -$5.23 M(-12.0%) | -$19.81 M(+17.1%) |
| Jun 2017 | - | -$5.95 M(-31.0%) | -$16.91 M(+25.1%) |
| Mar 2017 | - | -$8.62 M(+268.5%) | -$13.52 M(+7.7%) |
| Dec 2016 | -$8.79 M(-30.0%) | - | - |
| Sep 2016 | - | -$2.34 M(-8.3%) | -$12.54 M(-8.6%) |
| Sep 2016 | -$12.54 M(-31.1%) | - | - |
| Jun 2016 | - | -$2.55 M(-32.1%) | -$13.72 M(-18.6%) |
| Mar 2016 | - | -$3.76 M(-3.4%) | -$16.85 M(+1.2%) |
| Dec 2015 | - | -$3.89 M(+10.7%) | -$16.65 M(-8.5%) |
| Sep 2015 | -$18.20 M(-3.0%) | -$3.52 M(-38.1%) | -$18.20 M(+0.3%) |
| Jun 2015 | - | -$5.68 M(+59.2%) | -$18.15 M(+9.2%) |
| Mar 2015 | - | -$3.57 M(-34.4%) | -$16.63 M(-15.4%) |
| Dec 2014 | - | -$5.44 M(+57.1%) | -$19.66 M(+4.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2014 | -$18.77 M(+0.5%) | -$3.46 M(-16.7%) | -$18.77 M(-0.8%) |
| Jun 2014 | - | -$4.16 M(-37.1%) | -$18.93 M(+1.4%) |
| Mar 2014 | - | -$6.60 M(+45.1%) | -$18.67 M(+1.2%) |
| Dec 2013 | - | -$4.55 M(+25.8%) | -$18.45 M(-1.2%) |
| Sep 2013 | -$18.67 M(+11.4%) | -$3.62 M(-7.3%) | -$18.67 M(-9.2%) |
| Jun 2013 | - | -$3.90 M(-38.8%) | -$20.55 M(+0.1%) |
| Mar 2013 | - | -$6.38 M(+33.5%) | -$20.53 M(+14.9%) |
| Dec 2012 | - | -$4.78 M(-13.1%) | -$17.86 M(+6.6%) |
| Sep 2012 | -$16.76 M(-9.1%) | -$5.50 M(+41.7%) | -$16.76 M(+14.7%) |
| Jun 2012 | - | -$3.88 M(+4.6%) | -$14.61 M(+2.1%) |
| Mar 2012 | - | -$3.71 M(+1.1%) | -$14.31 M(-7.2%) |
| Dec 2011 | - | -$3.67 M(+9.6%) | -$15.42 M(-16.4%) |
| Sep 2011 | -$18.44 M(-46.8%) | -$3.35 M(-6.5%) | -$18.44 M(-0.9%) |
| Jun 2011 | - | -$3.58 M(-25.7%) | -$18.61 M(-22.8%) |
| Mar 2011 | - | -$4.82 M(-27.9%) | -$24.10 M(-7.7%) |
| Dec 2010 | - | -$6.69 M(+90.1%) | -$26.12 M(-24.7%) |
| Sep 2010 | -$34.67 M(-3.4%) | -$3.52 M(-61.2%) | -$34.67 M(-15.6%) |
| Jun 2010 | - | -$9.06 M(+32.4%) | -$41.09 M(+3.6%) |
| Mar 2010 | - | -$6.84 M(-55.1%) | -$39.65 M(-5.1%) |
| Dec 2009 | - | -$15.24 M(+53.4%) | -$41.80 M(+16.4%) |
| Sep 2009 | -$35.90 M(-4.7%) | -$9.94 M(+30.4%) | -$35.90 M(-4.3%) |
| Jun 2009 | - | -$7.62 M(-15.3%) | -$37.53 M(-5.9%) |
| Mar 2009 | - | -$9.00 M(-3.7%) | -$39.90 M(+0.9%) |
| Dec 2008 | - | -$9.34 M(-19.2%) | -$39.56 M(+5.0%) |
| Sep 2008 | -$37.69 M(+123.1%) | -$11.56 M(+15.7%) | -$37.69 M(+16.0%) |
| Jun 2008 | - | -$9.99 M(+15.4%) | -$32.49 M(+21.9%) |
| Mar 2008 | - | -$8.66 M(+15.8%) | -$26.66 M(+25.0%) |
| Dec 2007 | - | -$7.48 M(+17.4%) | -$21.34 M(+26.3%) |
| Sep 2007 | -$16.89 M(+296.0%) | -$6.37 M(+52.9%) | -$16.89 M(+60.5%) |
| Jun 2007 | - | -$4.16 M(+25.0%) | -$10.52 M(+65.5%) |
| Mar 2007 | - | -$3.33 M(+10.0%) | -$6.36 M(+110.0%) |
| Dec 2006 | - | -$3.03 M | -$3.03 M |
| Sep 2006 | -$4.26 M(+42.8%) | - | - |
| Sep 2005 | -$2.99 M | - | - |
FAQ
- What is Albireo Pharma annual free cash flow?
- What is the all time high annual FCF for Albireo Pharma?
- What is Albireo Pharma annual FCF year-on-year change?
- What is Albireo Pharma quarterly free cash flow?
- What is the all time high quarterly FCF for Albireo Pharma?
- What is Albireo Pharma quarterly FCF year-on-year change?
- What is Albireo Pharma TTM free cash flow?
- What is the all time high TTM FCF for Albireo Pharma?
- What is Albireo Pharma TTM FCF year-on-year change?
What is Albireo Pharma annual free cash flow?
The current annual FCF of ALBO is -$108.02 M
What is the all time high annual FCF for Albireo Pharma?
Albireo Pharma all-time high annual free cash flow is -$2.99 M
What is Albireo Pharma annual FCF year-on-year change?
Over the past year, ALBO annual free cash flow has changed by -$6.92 M (-6.84%)
What is Albireo Pharma quarterly free cash flow?
The current quarterly FCF of ALBO is -$29.67 M
What is the all time high quarterly FCF for Albireo Pharma?
Albireo Pharma all-time high quarterly free cash flow is $1.05 M
What is Albireo Pharma quarterly FCF year-on-year change?
Over the past year, ALBO quarterly free cash flow has changed by -$2.00 M (-7.23%)
What is Albireo Pharma TTM free cash flow?
The current TTM FCF of ALBO is -$116.28 M
What is the all time high TTM FCF for Albireo Pharma?
Albireo Pharma all-time high TTM free cash flow is -$3.03 M
What is Albireo Pharma TTM FCF year-on-year change?
Over the past year, ALBO TTM free cash flow has changed by +$6.05 M (+4.94%)